Publications by authors named "Albert Roger"

Claim this Profile
C
Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective analysis.
Maria Basagaña, Carlos Martínez-Rivera, Clara Padró, Ignasi Garcia-Olivé, Mimar Martínez-Colls, Albert Roger

Ann Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.
Cristina López, Nathalie Depreux, Isabel Bielsa, Albert Roger, Bibiana Quirant-Sanchez

Front Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and Factors Associated with Poor Asthma Control in Adults with Severe Eosinophilic Asthma.
Clara Padró-Casas, María Basagaña, María Luisa Rivera-Ortún, Ignasi García-Olivé, Carlos Pollan-Guisasola, Albert Roger

J Pers Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Component-Resolved Diagnosis to Characterize the Sensitization to Specific Cat and Dog Allergens in Patients with Allergic Respiratory Diseases in Catalonia, Spain.
Albert Roger, Carlota Lazo, Noelia Arias, Bibiana Quirant, Nereida Albert

Int Arch Allergy Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of a microcrystalline tyrosine-adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real-life prospective observational study.
Clara Padró, Diego Gutiérrez, Francisco Moreno, Antonio Parra, Manuel J Rial, Albert Roger

Immun Inflamm Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapy.
José L Justicia, Clara Padró, Albert Roger, Francisco Moreno, Manuel J Rial

World Allergy Organ J· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life effect of a microcrystalline tyrosine adjuvanted mite immunotherapy in patients with allergic rhinitis.
Albert Roger, Alfons Malet, Victoria Moreno, Antonio Parra, Diego Gutiérrez

Immunotherapy· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotheraphy in Allergic Diseases.
Albert Roger, Maria Basagana, Aina Teniente-Serra, Nathalie Depreux, Yanina Jurgens

Curr Pharm Des· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized dose-response study of subcutaneous immunotherapy with a Dermatophagoides pteronyssinus extract in patients with respiratory allergy.
Victoria Moreno, Marta Alvariño, Fernando Rodríguez, Albert Roger, María Isabel Peña-Arellano

Immunotherapy· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel microcrystalline tyrosine-adsorbed, mite-allergoid subcutaneous immunotherapy: 1-year follow-up report.
Albert Roger, Nathalie Depreux, Yanina Jurgens, Aina T Serra, Matthew D Heath

Immunotherapy· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A budget impact analysis of Spiromax(®) compared with Turbuhaler(®) for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions.
Josep Darbà, Gabriela Ramírez, Juan L García-Rivero, Sagrario Mayoralas-Alises, José Francisco Pascual, Albert Roger

Clinicoecon Outcomes Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Study of Patients' Compliance with Sublingual Immunotherapy in House Dust Mite Perennial Allergic Rhinitis.
Alfonso Malet, Angel Azpeitia, Diego Gutiérrez, Francisco Moreno, María Del Mar San Miguel Moncín, Albert Roger

Adv Ther· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of the value of innovation in inhalers for COPD and asthma.
Johann Christian Virchow, Cezmi A Akdis, Josep Darba, Richard Dekhuijzen, Sylvia Hartl, Albert Roger

J Mark Access Health Policy· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel and well tolerated mite allergoid subcutaneous immunotherapy: evidence of clinical and immunologic efficacy.
Albert Roger, Nathalie Depreux, Yani Jurgens, Matthew D Heath, Gloria Garcia

Immun Inflamm Dis· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational study of the safety of an ultra-rush sublingual immunotherapy regimen to treat rhinitis due to house dust mites.
Albert Roger, José-Luis Justicia, Luis Ángel Navarro, José Luis Eseverri, Jeroni Ferrès

Int Arch Allergy Immunol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of different liquid chromatography/mass spectrometry technologies for the identification of transformation products of rhodamine B in groundwater.
Alexander Müller, Stefan C Weiss, Wolfgang Schulz, Wolfram Seitz, Roger Albert

Rapid Commun Mass Spectrom· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient assessment of onset of action and overall satisfaction with ebastine fast-dissolving tablets in allergic rhinitis.
Albert Roger, Josep Fortea, Sheila Mora, Maite Artés

Expert Rev Pharmacoecon Outcomes Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis